Electrolytes for Long COVID Dysautonomia: What the Evidence Says

Dysautonomia — particularly postural orthostatic tachycardia syndrome (POTS) — has emerged as one of the most common and debilitating manifestations of Long COVID. Studies suggest that 30–60% of Long COVID patients meet criteria for POTS or a POTS-like syndrome, characterized by excessive heart rate increases upon standing, dizziness, brain fog, and profound fatigue. For these patients, the same electrolyte strategies that benefit classic POTS patients are directly applicable — and the evidence supporting their use is growing.

Why Long COVID Dysautonomia Responds to Electrolytes

The autonomic dysfunction in Long COVID appears to involve several mechanisms, including autoantibodies against autonomic receptors, small fiber neuropathy, mast cell activation, and hypovolemia (reduced blood volume). The hypovolemia component is particularly relevant to electrolyte therapy: multiple studies have documented reduced plasma volume in Long COVID patients, consistent with the blood volume deficits seen in classic POTS.

When blood volume is low, the cardiovascular system struggles to maintain adequate perfusion when upright. Sodium and fluid intake directly addresses this by expanding plasma volume. The mechanism is identical to classic POTS — and the clinical response to sodium loading in Long COVID dysautonomia patients is similarly meaningful.

A 2022 study from the Vanderbilt Autonomic Dysfunction Center found that Long COVID patients with POTS had plasma volume deficits comparable to those seen in classic POTS, and that non-pharmacological interventions including increased salt and fluid intake produced significant improvements in orthostatic heart rate and symptoms.

What's Different About Long COVID Dysautonomia

While the electrolyte strategies are similar, Long COVID dysautonomia has several features that require specific attention:

Mast cell activation. MCAS is significantly more common in Long COVID than in classic POTS, and many Long COVID patients react to commercial electrolyte products containing common MCAS triggers (citric acid, natural flavors, stevia, artificial colors). Choosing clean, minimal-ingredient products — such as Buoy Rescue Drops or plain salt and water — is particularly important for Long COVID patients with suspected or confirmed MCAS.

Post-exertional malaise (PEM). Many Long COVID patients have ME/CFS-like PEM, in which physical or cognitive exertion triggers a worsening of symptoms that can last days to weeks. Exercise-based POTS rehabilitation, which is a cornerstone of classic POTS management, must be approached extremely cautiously in Long COVID patients with PEM. Electrolyte management becomes even more important as a non-exercise intervention that can improve symptoms without triggering PEM.

Fluctuating symptoms. Long COVID symptoms often fluctuate significantly from day to day and week to week. Electrolyte needs may vary accordingly — patients may need to increase intake during flares and can reduce it during better periods.

Concurrent medications. Long COVID patients are often prescribed multiple medications, some of which interact with electrolyte management. Antihistamines (for MCAS), low-dose naltrexone, and other treatments may affect fluid balance and electrolyte needs.

Practical Electrolyte Recommendations for Long COVID

The electrolyte recommendations for Long COVID dysautonomia are broadly similar to those for classic POTS:

Daily sodium target: 3,000–5,000 mg from all sources (food plus supplements) as a starting point, with adjustment based on symptom response.

Fluid intake: 2–3 liters per day of water and electrolyte-containing fluids. Plain water alone is insufficient — electrolytes must accompany fluid intake to achieve meaningful blood volume expansion.

Product selection: For Long COVID patients with MCAS or multiple sensitivities, Buoy Rescue Drops are often the best-tolerated commercial option due to their completely clean ingredient list. For patients without MCAS, LMNT, DripDrop, or other products may be appropriate based on individual tolerance and sodium needs.

Timing: Consuming electrolytes before getting out of bed in the morning — before the first orthostatic challenge of the day — can significantly reduce morning symptoms. Spacing additional servings throughout the day maintains more consistent blood volume.

Monitoring: Tracking symptoms alongside electrolyte intake helps identify the optimal dose and timing. Many Long COVID patients find that their electrolyte needs are higher during flares and can be reduced during better periods.

When to Seek Additional Support

Electrolytes are an important part of Long COVID dysautonomia management but are rarely sufficient as a standalone treatment. Patients whose symptoms are significantly impairing daily function should seek evaluation by a cardiologist or neurologist with experience in dysautonomia, who can assess for POTS, prescribe medications if appropriate, and coordinate a comprehensive management plan.

The Long COVID research landscape is evolving rapidly, and new treatment approaches are emerging. Staying connected with Long COVID patient organizations and research updates — through resources like ChatDys — helps patients access the most current information.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your treatment plan.